CLINICAL_TRIALS
trial_result
· 2014-11-25
Clinical Trial Update: Escitalopram in the Treatment of Dysthymic Disorder, Double Blind [Phase 4]
Summary
ClinicalTrials.gov updates a Phase 4 trial of escitalopram for dysthymic disorder, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: Dysthymic Disorder | Phase 4 | Status: COMPLETED | Results posted: 2014-11-25